Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ophthalmology and cancer.
| EPIC: | ALXN |
| Market: | NASDAQ:ALXN |
| 52-week High/Low: | $141.81 / $92.57 |
| Sector: | Pharmaceuticals |
| Market Cap: | $29,780.31 m |
| Website: | www.alexionpharma.com |
col 3
col 4
col 5
col 6
Alexion Pharmaceuticals Timeline
Newswire
September 24 2018
Article
March 15 2018
Article
September 12 2017
